M/23/034 – PCI/Certain Assets of Wasdell
Transaction details
The proposed acquisition by Millmount Healthcare Limited (t/a PCI Pharma Services) of certain assets of Wasdell Europe Limited has been cleared by the Competition and Consumer Protection Commission.
| Notification date | Decision date |
|---|---|
| Monday June 17, 2024 | Thursday, July 4, 2024 |
| Parties Involved | Business activities |
|---|---|
| Wasdell Europe Limited | Wasdell Europe Limited ("Wasdell") offers supply chain services in respect of pharmaceutical products. Wasdell operates across multiple sites in Europe and ships to over 47 countries globally. |
| PCI Pharma Services Group | Millmount Healthcare Limited is a company in the PCI Pharma Services Group ("PCI Group"). PCI Group is a contract development and manufacturing organisation ("CDMO") which is headquartered in Pennsylvania, USA, and operates globally. PCI Group offers the full suite of drug development and manufacturing services to the pharmaceutical industry. In the State, PCI Group offers CDMO services from two good manufacturing practices (GMP) facilities located in Drogheda, County Louth, and Stamullen, County Meath. |
| Economic sector | Media merger |
|---|---|
| Healthcare | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Monday, July 1, 2024 | |
| Current status: Completed |
|---|
| Cleared (Phase 1) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Louis O'Carroll | louisocarroll@ccpc.ie |
Media enquiries: communications@ccpc.ie
Haven’t found what you’re looking for?
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555